The Traderszone Network

Published in TZ Latest News 19 June, 2016 by The TZ Newswire Staff

Gilead Sciences: Where’s the Value?

Money And Pills On Scale

Image source: Getty Images.

Over the past year, Gilead Sciences‘ (NASDAQ: GILD) shares have steadily marched lower due to the flattening sales of its hep C drug Harvoni.

Continue reading